Evidence database

Best practice portal main page

Contingency management for patients with psychotic and substance use disorders

Summary of the evidence

Rating
  • Likely to be beneficial

Contingency management in psychotic patients with Substance Use Disorders (SUD) was found in a systematic review with meta analysis (Destoop et al., 2021) to be effective compared to standard care in:

  • Improving abstinence rates of drug use, measured by:
    • self-reported lower number of days using substance (SMD = −0.52, 95% CI −0.98 to −0.06; p = 0.03
    • tendency to more negative breath or urine samples for substance use (OR 2.13, 95% CI 0.97 to 4.69; p = 0.06)

However no differences among retention in treatment (RR 1.15, 95% CI 0.90 to 1.45; p = 0.26).

Details

Note: this evidence summary is only valid for the outcomes, target groups, settings and substances/patterns of use described below.

Name of response option
  • Integrated co-morbidity treatment
Desired outcome(s)
  • improve mental health outcomes
  • reduce substance use
Area(s)
  • Treatment
Specific substance or pattern of use
  • not-drug specific
Target group(s) or setting(s)
  • dual-diagnosis patients

References

Explore all resources in the Best practice portal

 

Miniguides

A one-stop-shop for anyone planning or delivering health and social responses.

 

Implementation

Implementation inventories including Xchange, Healthy Nightlife Toolbox, EUPC and EIB

 

Evidence

All of the latest research and evidence on drug-related interventions.

 

Standards

Standards and guidelines for drug-related interventions, aimed at improving their quality.

About the Best practice portal

Collaborations and partnerships in best practice

Logo of the Cochrane Collaboration
Logo of the Campbell Collaboration
Grade logo
WHO logo
Top